Prasol Chemicals IPO is a book-built mainboard public issue of Prasol Chemicals Limited, an Indian specialty chemicals manufacturer with more than three decades of operating experience.
The company manufactures acetone-based specialty chemicals, phosphorus-based specialty chemicals and other chemicals involving complex and differentiated chemistries. Its products serve industries such as performance chemicals, paints, inks, construction and adhesives, pharmaceuticals, agrochemicals, and home and personal care.
The IPO is scheduled to open for subscription on 8 September 2026 and close on 10 September 2026. The price band has been fixed at ₹643 to ₹676 per equity share, with a face value of ₹2 per share. The shares are proposed to be listed on the BSE and NSE.
The total issue size is ₹500 crore, consisting of a fresh issue of approximately ₹80 crore and an offer for sale of approximately ₹420 crore. The offer comprises approximately 73,96,437 equity shares, including 11,83,431 fresh shares and 62,13,006 shares offered by selling shareholders.
Table of Contents
Prasol Chemicals IPO Details
| Particular | Details |
|---|---|
| IPO Name | Prasol Chemicals IPO |
| Company Name | Prasol Chemicals Limited |
| Issue Type | Book Built Issue |
| IPO Category | Mainboard IPO |
| Face Value | ₹2 Per Equity Share |
| Price Band | ₹643 to ₹676 Per Share |
| Total Issue Size | ₹500 Crore |
| Fresh Issue | ₹80 Crore |
| Fresh Issue Shares | 11,83,431 Equity Shares |
| Offer for Sale | 62,13,006 Equity Shares |
| OFS Value | ₹420 Crore |
| Total Shares Offered | 73,96,437 Equity Shares |
| IPO Open Date | 8 September 2026 |
| IPO Close Date | 10 September 2026 |
| Basis of Allotment | 11 September 2026 |
| Refund Initiation | 15 September 2026 |
| Credit to Demat | 15 September 2026 |
| Listing Date | 16 September 2026 |
| Listing Exchange | BSE & NSE |
| Lot Size | 22 Shares |
| Minimum Retail Investment | ₹14,872 |
| Lead Manager | DAM Capital Advisors Limited |
| Registrar | KFin Technologies Limited |
Only the fresh issue proceeds will accrue to Prasol Chemicals. The proceeds from the OFS will go to the respective selling shareholders.
Prasol Chemicals IPO Dates & Timeline
| IPO Event | Date |
|---|---|
| Anchor Investor Bidding | 7 September 2026 |
| IPO Opening Date | 8 September 2026 |
| IPO Closing Date | 10 September 2026 |
| Basis of Allotment | 11 September 2026 |
| Refund Initiation | 15 September 2026 |
| Credit to Demat Account | 15 September 2026 |
| IPO Listing Date | 16 September 2026 |
The anchor book is scheduled to open on 7 September 2026, one day before the public issue. The public bidding period will run from 8 September to 10 September, followed by allotment on 11 September and listing on 16 September.
Prasol Chemicals IPO Price Band
The Prasol Chemicals IPO price band is fixed at ₹643 to ₹676 per equity share.
| Particular | Amount |
|---|---|
| Face Value | ₹2 |
| Lower Price Band | ₹643 |
| Upper Price Band | ₹676 |
| Fresh Issue | ₹80 Crore |
| Offer for Sale | ₹420 Crore |
| Total Issue Size | ₹500 Crore |
At the upper price band, the total IPO is valued at approximately ₹500 crore.
Prasol Chemicals IPO Lot Size
The Prasol Chemicals IPO market lot is 22 shares.
At the upper price band of ₹676, one lot requires an investment of ₹14,872.
| Application | Lots | Shares | Amount at ₹676 |
|---|---|---|---|
| Retail Minimum | 1 | 22 | ₹14,872 |
| Retail Maximum | 13 | 286 | ₹1,93,336 |
| S-HNI Minimum | 14 | 308 | ₹2,08,208 |
| S-HNI Maximum | 67 | 1,474 | ₹9,96,424 |
| B-HNI Minimum | 68 | 1,496 | ₹10,11,296 |
Investors can bid in multiples of 22 shares, subject to the applicable investor-category limits.
Prasol Chemicals IPO Reservation
| Investor Category | Reservation |
|---|---|
| Qualified Institutional Buyers | 50% |
| Non-Institutional Investors | 15% |
| Retail Individual Investors | 35% |
| Total | 100% |
The issue provides up to 50% of the net offer for QIBs, at least 15% for NIIs and at least 35% for retail investors.
About Prasol Chemicals Limited
Prasol Chemicals Limited was incorporated in 1992 and operates in the specialty chemicals industry.
The company describes itself as a forward-integrated manufacturer of acetone-based, phosphorus-based and other specialty chemicals involving complex and differentiated chemistries. Its product portfolio contains more than 150 specialty chemical products.
As of 30 June 2026, the portfolio consisted of:
- 21 acetone-based specialty chemicals
- 53 phosphorus-based specialty chemicals
- 76 other specialty chemicals
These products include surfactants, performance additives, ethers, esters, polymers, acids and other customised chemical products.
The company has developed a diversified customer base and supplies chemicals used as raw materials and intermediates across several industries.
Prasol Chemicals Business
Prasol Chemicals operates mainly in the specialty chemicals segment, focusing on products where chemistry, quality, application performance and technical know-how are important.
Its five major application areas are:
- Performance chemicals
- Paints, inks, construction and adhesives
- Pharmaceuticals
- Agrochemicals
- Home and personal care
The performance chemicals portfolio includes products used in areas such as lubricant additives and mining chemicals. The PICA category covers paints, inks, construction and adhesives.
The company has also developed specialised capabilities in acetone and phosphorus-based chemistry.
Prasol Chemicals Product Portfolio
| Product Category | Number of Products | Major Applications |
|---|---|---|
| Acetone-Based Chemicals | 21 | Specialty chemical applications |
| Phosphorus-Based Chemicals | 53 | Lubricants, mining and other applications |
| Other Specialty Chemicals | 76 | Pharmaceuticals, agrochemicals, personal care and industrial applications |
| Total | 150+ | Multiple industries |
The diversified portfolio allows the company to serve several end-use industries rather than depending on a single application segment.
Prasol Chemicals Customer Base
Prasol Chemicals has a broad B2B customer base.
The company had more than 1,600 customers and a distribution network extending to 69 countries as of the relevant 2026 reporting dates. Its customer base includes companies such as Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science and Technology, Gharda Chemicals, Croda India, Supriya Lifescience and Yasho Industries.
The company has also reported long-standing customer relationships across several application industries.
Prasol Chemicals Manufacturing Facilities
Prasol Chemicals operates two manufacturing facilities in Maharashtra:
- Khopoli
- Mahad
The aggregate installed capacity of the two facilities reached approximately 98,644 metric tonnes per annum in FY2026.
Manufacturing Capacity
| Facility | FY2026 Installed Capacity | FY2026 Production | Utilisation |
|---|---|---|---|
| Khopoli | 78,784 MT | 63,256 MT | 80.29% |
| Mahad | 19,860 MT | 8,756 MT | 44.09% |
| Total | 98,644 MT | 72,012 MT | — |
The Khopoli facility operated at a considerably higher utilisation level than Mahad during FY2026. The available capacity at Mahad provides potential room for higher production if demand and operating conditions support increased utilisation.
Prasol Chemicals Research & Development
Research and development is an important part of the company’s specialty-chemicals strategy.
As of 30 June 2026, Prasol Chemicals had an in-house R&D team of 37 members, including four PhD holders and 25 chemists. The company had approximately 40 products in its R&D pipeline and had commercialised 13 new products since 1 April 2023.
The development of new specialty chemicals can help the company expand its product portfolio and address changing requirements from customers.
Prasol Chemicals Export Business
Prasol Chemicals has a significant international presence.
The company is a 3 Star Export House and exports specialty chemicals to multiple international markets. Its distribution network covers countries across Asia-Pacific, North America, South America and Europe.
The company has stated that its revenue mix is predominantly domestic, with approximately 73% of average revenue coming from the domestic market and the remainder from exports.
Prasol Chemicals IPO Objects of the Issue
The company proposes to utilise the net proceeds from the fresh issue primarily for repayment or pre-payment of borrowings.
| Object of the Issue | Amount |
|---|---|
| Repayment / Pre-payment of Certain Borrowings | ₹60.00 Crore |
| General Corporate Purposes | Balance Amount |
| Total Fresh Issue | ₹80.00 Crore |
The company plans to use ₹60 crore of the fresh issue proceeds for repayment and/or pre-payment of certain borrowings. The remaining amount is intended for general corporate purposes, subject to applicable limits.
Prasol Chemicals IPO Financials
Prasol Chemicals has reported substantial growth in revenue and profitability during the last three financial years.
Revenue increased from ₹887.56 crore in FY2024 to ₹1,015.54 crore in FY2025 and ₹1,237.85 crore in FY2026.
Profit after tax increased from ₹18.13 crore in FY2024 to ₹43.57 crore in FY2025 and ₹83.12 crore in FY2026.
Prasol Chemicals Financial Performance
₹ in Crore
| Particular | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Total Income | 887.56 | 1,015.54 | 1,237.85 |
| EBITDA | 60.53 | 87.77 | 139.32 |
| Profit After Tax | 18.13 | 43.57 | 83.12 |
| Net Worth | 325.84 | 367.46 | 448.51 |
| Total Assets | 626.36 | 723.09 | 839.28 |
| Reserves & Surplus | 314.24 | 355.87 | 436.91 |
| Total Borrowings | 82.07 | 101.05 | 110.06 |
The company delivered strong growth in both revenue and profit between FY2024 and FY2026.
Prasol Chemicals Financial Highlights
Revenue increased by approximately 39.4% between FY2024 and FY2026.
PAT increased more than four times over the same period, rising from ₹18.13 crore to ₹83.12 crore.
EBITDA increased from ₹60.53 crore in FY2024 to ₹139.32 crore in FY2026.
The improvement in profitability has been accompanied by growth in net worth, which reached ₹448.51 crore as of 31 March 2026.
At the same time, borrowings increased to ₹110.06 crore in FY2026 from ₹82.07 crore in FY2024. Therefore, investors should consider both earnings growth and the company’s working-capital and borrowing requirements.
Prasol Chemicals IPO Key Performance Indicators
| KPI | FY2026 |
|---|---|
| ROE | 20.37% |
| ROCE | 22.43% |
| RoNW | 18.53% |
| EBITDA Margin | 11.30% |
| PAT Margin | 6.74% |
| Debt/Equity | 0.19x |
| EPS | ₹14.33 |
| NAV | ₹77.33 |
The latest reported period shows a 22.43% ROCE and 18.53% RoNW, while the debt-to-equity ratio stood at approximately 0.19x.
Prasol Chemicals IPO Valuation
At the upper price band of ₹676, Prasol Chemicals is expected to have a post-issue market capitalisation of approximately ₹4,000.80 crore.
Based on FY2026 earnings and the post-IPO share capital, the IPO is valued at approximately 48x FY2026 earnings. The valuation is therefore an important factor for investors to consider alongside the company’s earnings growth and future prospects.
| Valuation Parameter | Value |
|---|---|
| Upper Price Band | ₹676 |
| FY2026 EPS | ₹14.33 |
| NAV | ₹77.33 |
| Post-IPO Market Capitalisation | ₹4,000.80 Crore |
| Approx. P/E on FY2026 Post-Issue Earnings | 48.11x |
| P/BV at Upper Band | 8.74x |
| Post-IPO P/BV | 7.57x |
| ROE | 20.37% |
| ROCE | 22.43% |
| Debt/Equity | 0.19x |
The offer document’s peer group includes companies such as Aarti Industries, Atul, Laxmi Organic Industries, Vinati Organics, Privi Speciality Chemicals, Yasho Industries and Excel Industries.
Prasol Chemicals IPO GMP
The grey market premium is an unofficial indicator of market sentiment before listing and is not guaranteed.
As of 4 September 2026, reported GMP indications were around ₹13–₹14 per share. Using ₹14 as the indicative GMP and the upper price band of ₹676, the implied grey-market price would be around ₹690.
| Particular | Value |
|---|---|
| Upper IPO Price | ₹676 |
| Reported GMP | Around ₹14 |
| Indicative GMP Price | Around ₹690 |
| Indicative Premium | Around 2.07% |
| GMP Status | Unofficial |
GMP can change quickly before and during the IPO. Investors should not consider it a guaranteed listing price or investment return.
Prasol Chemicals IPO Subscription Status
The Prasol Chemicals IPO is scheduled to open on 8 September 2026 and close on 10 September 2026.
As of 4 September 2026, the public issue has not opened, so final subscription figures are not available.
| Investor Category | Subscription Status |
|---|---|
| QIB | Not Yet Open |
| NII | Not Yet Open |
| Retail | Not Yet Open |
| Total | Not Yet Open |
The subscription figures should be updated once bidding begins.
Prasol Chemicals IPO Allotment
The basis of allotment is scheduled for 11 September 2026.
| Event | Date |
|---|---|
| IPO Closing | 10 September 2026 |
| Basis of Allotment | 11 September 2026 |
| Refund Initiation | 15 September 2026 |
| Credit to Demat | 15 September 2026 |
| Listing | 16 September 2026 |
Investors can check their allotment after the basis of allotment is finalised.
How to Check Prasol Chemicals IPO Allotment Status
The allotment status can be checked after finalisation through the registrar or applicable stock exchange facility.
Through the Registrar
- Visit the IPO allotment facility of the registrar.
- Select Prasol Chemicals Limited.
- Select the required identification method.
- Enter the PAN, application number or other requested information.
- Submit the details.
- Check the allotment result.
The registrar to the issue is KFin Technologies Limited.
Through Stock Exchanges
Investors can also check application status through the relevant BSE or NSE facility after the allotment information is made available.
Prasol Chemicals IPO Listing
Prasol Chemicals shares are scheduled to list on the BSE and NSE on 16 September 2026.
The actual listing price will depend on market conditions, demand and trading activity on the listing day.
| Particular | Details |
|---|---|
| Listing Exchange | BSE & NSE |
| Listing Date | 16 September 2026 |
| IPO Price Band | ₹643–₹676 |
| Actual Listing Price | To Be Announced |
| Listing Gain | To Be Announced |
| Listing Gain % | To Be Announced |
The GMP-based implied price should not be confused with the actual listing price.
Prasol Chemicals IPO Anchor Investors
The anchor investor bidding is scheduled for 7 September 2026.
| Particular | Details |
|---|---|
| Anchor Bidding Date | 7 September 2026 |
| QIB Reservation | 50% |
| Anchor Investor Names | To Be Announced |
| Anchor Shares | To Be Announced |
| Anchor Amount | To Be Announced |
| Public Issue Opens | 8 September 2026 |
The final anchor allocation details should be updated after the anchor book is completed.
Prasol Chemicals IPO Promoters
The promoters of Prasol Chemicals Limited are:
- Nishith Rajnikant Shah
- Gaurang Natwarlal Parikh
- Dhaval Nalin Parikh
- Pankil Nishith Dharia
- Sachin Jatin Parikh
- Rakesh Gupta
- Nishith Rasiklal Dharia
- Kunal Tushar Dharia
- Suketu Navinchandra Parikh
- Usha Rajnikant Shah
The promoter and promoter-group holding is reported at approximately 89.20% before the IPO. The post-issue holding is expected to reduce as a result of the fresh issue and OFS.
Prasol Chemicals Shareholding
| Particular | Pre-IPO | Post-IPO |
|---|---|---|
| Promoter & Promoter Group | 89.20% | 76.92% |
| Others | 10.80% | 23.08% |
| Total | 100% | 100% |
The dilution will increase the public shareholding after listing.
Prasol Chemicals IPO Selling Shareholders
The IPO includes an offer for sale of up to 62,13,006 equity shares.
The OFS forms the larger component of the IPO, accounting for approximately 84% of the ₹500 crore issue at the upper price band, while the fresh issue represents approximately 16%.
Investors should therefore distinguish between funds raised by the company and proceeds received by existing shareholders.
Prasol Chemicals IPO Lead Manager
| Particular | Details |
|---|---|
| Lead Manager | DAM Capital Advisors Limited |
| Role | Book Running Lead Manager |
| Issue Type | Mainboard Book-Built IPO |
| Listing | BSE & NSE |
DAM Capital Advisors Limited is the sole book-running lead manager for the IPO.
Prasol Chemicals IPO Registrar
| Particular | Details |
|---|---|
| Registrar | KFin Technologies Limited |
| Role | Registrar to the Issue |
| IPO | Prasol Chemicals Limited |
KFin Technologies Limited has been appointed as the registrar to the Prasol Chemicals IPO.
Prasol Chemicals Company Details
| Particular | Details |
|---|---|
| Company Name | Prasol Chemicals Limited |
| Incorporation | 1992 |
| Industry | Specialty Chemicals |
| Main Products | Acetone-based, phosphorus-based and other specialty chemicals |
| Manufacturing Facilities | Khopoli and Mahad, Maharashtra |
| Installed Capacity | 98,644 MT per annum |
| Product Portfolio | 150+ Specialty Chemicals |
| Customers | 1,600+ |
| Export Reach | 69 Countries |
| Promoters | Nishith Rajnikant Shah and promoter group |
| Listing Exchange | BSE & NSE |
| Registered Office | Prasol House, TTC Industrial Area, Khairne MIDC, Navi Mumbai, Maharashtra – 400710 |
| Company Website | https://www.prasolchem.com/ |
The company operates from two manufacturing facilities in Maharashtra and serves multiple domestic and international customers.
Prasol Chemicals IPO Strengths
- More than three decades of experience in specialty chemicals.
- Diversified portfolio of more than 150 specialty chemical products.
- Products based on acetone, phosphorus and other complex chemistries.
- Presence across five major application industries.
- More than 1,600 customers.
- Exports and distribution presence across 69 countries.
- 3 Star Export House certification.
- Two manufacturing facilities in Maharashtra.
- Aggregate manufacturing capacity of 98,644 MT per annum.
- Strong capacity utilisation at the Khopoli facility.
- In-house R&D capabilities.
- R&D team of 37 members.
- Four PhD holders within the R&D team.
- Around 40 products in the R&D pipeline.
- 13 new products commercialised since April 2023.
- Company is the only manufacturer of isophorone in India according to the referenced industry report.
- It was among the largest importers of acetone in India during the relevant 2022–2025 period.
- Presence in performance chemicals, PICA, pharmaceuticals, agrochemicals and home and personal care.
- Long-standing relationships with several customers.
- Revenue increased from ₹887.56 crore in FY2024 to ₹1,237.85 crore in FY2026.
- PAT increased from ₹18.13 crore to ₹83.12 crore during the same period.
- EBITDA increased from ₹60.53 crore to ₹139.32 crore.
- Net worth increased to ₹448.51 crore in FY2026.
- ROCE of 22.43% in FY2026.
- RoNW of 18.53% in FY2026.
- Debt-to-equity ratio of approximately 0.19x.
- ₹60 crore of fresh IPO proceeds will be used to reduce borrowings.
Prasol Chemicals IPO Risks
- The specialty chemicals industry is highly competitive.
- The company is exposed to fluctuations in raw-material prices.
- Acetone and phosphorus-related raw materials are important inputs for several products.
- Changes in raw-material availability can affect production.
- Chemical businesses are subject to environmental and regulatory requirements.
- Manufacturing operations are concentrated in Maharashtra.
- The Mahad facility operated at a substantially lower utilisation rate than Khopoli in FY2026.
- Demand from end-use industries can fluctuate with economic conditions.
- International operations expose the company to foreign-market and currency risks.
- Customer relationships may not always continue at existing volumes.
- Product development requires continued R&D investment.
- New products may not achieve commercial success.
- Specialty chemicals require consistent quality and technical performance.
- Any disruption at manufacturing facilities could affect production and revenue.
- The company has reported increasing borrowings over the last three financial years.
- Trade receivables have increased over time, which can put pressure on working capital.
- The company has disclosed contingent liabilities and commitments.
- The IPO has a large OFS component.
- Approximately 84% of the total issue value represents the OFS component.
- OFS proceeds do not accrue to the company.
- Only ₹80 crore of the ₹500 crore issue represents fresh capital.
- The IPO valuation is relatively demanding at approximately 48x FY2026 earnings.
- The issue price is substantially above the company’s NAV.
- Future earnings growth may not continue at the same pace as FY2025–FY2026.
- GMP is unofficial and can change rapidly.
- Post-listing share-price volatility may be significant.
Prasol Chemicals IPO Review 2026
Prasol Chemicals operates in the specialty chemicals industry and has built a diversified portfolio covering more than 150 products. Its chemicals are used across performance chemicals, PICA, pharmaceuticals, agrochemicals and home and personal care. This diversification reduces dependence on a single end-use industry.
The company also has a broad customer and geographical base. It serves more than 1,600 customers and has an international distribution network covering 69 countries. Its customer list includes established names from pharmaceutical, chemical, agrochemical and specialty-chemical industries.
Manufacturing capacity is another positive factor. The Khopoli and Mahad facilities together have an installed capacity of 98,644 MT per annum. However, the utilisation levels of the two facilities were different in FY2026, with Khopoli operating at 80.29% and Mahad at 44.09%. Higher utilisation at Mahad could provide additional operating leverage if supported by demand and efficient execution.
The financial performance has improved considerably. Revenue rose from ₹887.56 crore in FY2024 to ₹1,237.85 crore in FY2026, while PAT increased from ₹18.13 crore to ₹83.12 crore. EBITDA also more than doubled during this period.
The balance sheet remains an important area to monitor. Net worth reached ₹448.51 crore in FY2026, while borrowings stood at ₹110.06 crore. The debt-to-equity ratio of approximately 0.19x remains moderate, but the company is using ₹60 crore from the fresh issue to repay or pre-pay certain borrowings.
The IPO structure is a key consideration. Of the ₹500 crore issue, only ₹80 crore is fresh capital, while ₹420 crore represents an OFS. Consequently, the majority of the issue proceeds will go to selling shareholders rather than the company.
The fresh proceeds will primarily be used for repayment or pre-payment of borrowings. While this can strengthen the balance sheet and reduce finance costs, the IPO does not provide a large amount of new growth capital for expansion.
Valuation is perhaps the biggest consideration. At the upper price band of ₹676, the company is valued at approximately ₹4,000.80 crore, with the issue working out to roughly 48x FY2026 earnings on a post-issue basis. This means investors are paying a substantial premium for the company’s recent earnings performance and future growth prospects.
The company does have several attractive characteristics, including specialty-chemical capabilities, a diversified product range, international exposure, an established customer base, R&D capabilities and strong recent profit growth.
However, investors should balance these positives against valuation, raw-material risks, chemical-industry cyclicality, manufacturing concentration, utilisation differences between facilities, working-capital requirements and the large OFS component.
Overall, Prasol Chemicals IPO offers exposure to an established specialty-chemicals business with strong recent earnings growth and a diversified product portfolio. However, the valuation appears demanding, making the IPO more suitable for investors who are comfortable with the company’s growth expectations and the risks associated with specialty chemicals.
Prasol Chemicals IPO Conclusion
Prasol Chemicals IPO is a ₹500 crore mainboard book-built issue comprising a fresh issue of ₹80 crore and an offer for sale of ₹420 crore. The price band is ₹643 to ₹676 per share, with a lot size of 22 shares.
The company operates in the specialty chemicals industry and manufactures more than 150 products based on acetone, phosphorus and other complex chemistries. It serves more than 1,600 customers and has an international distribution network across 69 countries.
Financial performance has improved strongly, with revenue rising from ₹887.56 crore in FY2024 to ₹1,237.85 crore in FY2026 and PAT increasing from ₹18.13 crore to ₹83.12 crore.
The company also has two manufacturing facilities with combined installed capacity of 98,644 MT per annum and an established R&D platform for developing new specialty chemicals.
The main concern is valuation. At ₹676 per share, the IPO is valued at approximately 48x FY2026 earnings. In addition, 84% of the issue is an OFS, meaning most IPO proceeds will go to existing shareholders rather than directly into the business.
Investors should therefore evaluate Prasol Chemicals based on its earnings growth, product portfolio, customer diversification, manufacturing capacity, R&D pipeline, leverage and future growth prospects rather than relying solely on GMP.
The IPO is scheduled to open on 8 September 2026, close on 10 September 2026, receive allotment on 11 September 2026 and list on 16 September 2026.
Prasol Chemicals IPO FAQs
What is Prasol Chemicals IPO?
Prasol Chemicals IPO is a mainboard book-built public issue of ₹500 crore comprising a fresh issue of ₹80 crore and an offer for sale of ₹420 crore.
What is the Prasol Chemicals IPO price band?
The price band is ₹643 to ₹676 per equity share.
What is the Prasol Chemicals IPO issue size?
The total issue size is ₹500 crore.
What is the Prasol Chemicals IPO lot size?
The IPO lot size is 22 shares.
What is the minimum investment in Prasol Chemicals IPO?
At the upper price band of ₹676, one lot of 22 shares requires ₹14,872.
When is Prasol Chemicals IPO allotment?
The basis of allotment is scheduled for 11 September 2026.
When will Prasol Chemicals shares be listed?
The shares are scheduled to list on the BSE and NSE on 16 September 2026.
What is Prasol Chemicals IPO GMP?
The reported GMP was around ₹13–₹14 per share on 4 September 2026. GMP is unofficial and can change before listing.
What does Prasol Chemicals Limited do?
Prasol Chemicals manufactures specialty chemicals, including acetone-based, phosphorus-based and other complex specialty chemicals used across performance chemicals, PICA, pharmaceuticals, agrochemicals, and home and personal care.
Who are the promoters of Prasol Chemicals?
The promoters include Nishith Rajnikant Shah, Gaurang Natwarlal Parikh, Dhaval Nalin Parikh, Pankil Nishith Dharia, Sachin Jatin Parikh, Rakesh Gupta, Nishith Rasiklal Dharia, Kunal Tushar Dharia, Suketu Navinchandra Parikh and Usha Rajnikant Shah.
